Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021
- PMID: 35177166
- PMCID: PMC8855507
- DOI: 10.2807/1560-7917.ES.2022.27.7.2200060
Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021
Abstract
Despite high COVID-19 vaccine coverage in the EU/EEA, there are increasing reports of SARS-CoV-2 infections and hospitalisations in vaccinated individuals. Using surveillance data from Estonia, Ireland, Luxembourg and Slovakia (January-November 2021), we estimated risk reduction of severe outcomes in vaccinated cases. Increasing age remains the most important driver of severity, and vaccination significantly reduces risk in all ages for hospitalisation (adjusted relative risk (aRR): 0.32; 95% confidence interval (CI): 0.26-0.39) and death (aRR: 0.20; 95% CI: 0.13-0.29).
Keywords: COVID-19; Europe Union; death; hospitalization; surveillance; vaccination; vaccine effectiveness.
Conflict of interest statement
Figures
Similar articles
-
Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland.Swiss Med Wkly. 2022 Apr 19;152:w30163. doi: 10.4414/smw.2022.w30163. eCollection 2022 Apr 11. Swiss Med Wkly. 2022. PMID: 35752951
-
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22. Lancet Infect Dis. 2022. PMID: 34562375 Free PMC article.
-
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.PLoS Med. 2021 Dec 17;18(12):e1003874. doi: 10.1371/journal.pmed.1003874. eCollection 2021 Dec. PLoS Med. 2021. PMID: 34919548 Free PMC article.
-
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34437525 Free PMC article.
-
An audit of COVID-19 death reporting in counties Cork and Kerry, Ireland, winter 2021-2022.Ir J Med Sci. 2023 Aug;192(4):1589-1594. doi: 10.1007/s11845-022-03211-7. Epub 2022 Nov 16. Ir J Med Sci. 2023. PMID: 36383325 Free PMC article. Review.
Cited by
-
Impact of COVID-19 vaccination in post-COVID cardiac complications.Vaccine. 2023 Feb 17;41(8):1524-1528. doi: 10.1016/j.vaccine.2023.01.052. Epub 2023 Jan 27. Vaccine. 2023. PMID: 36725436 Free PMC article.
-
The Role of Vaccination and Face Mask Wearing on COVID-19 Infection and Hospitalization: A Cross-Sectional Study of the MENA Region.Healthcare (Basel). 2023 Apr 28;11(9):1257. doi: 10.3390/healthcare11091257. Healthcare (Basel). 2023. PMID: 37174799 Free PMC article.
-
Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.Euro Surveill. 2023 Feb;28(5):2200337. doi: 10.2807/1560-7917.ES.2023.28.5.2200337. Euro Surveill. 2023. PMID: 36729113 Free PMC article.
-
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination.iScience. 2023 Jun 25;26(7):107208. doi: 10.1016/j.isci.2023.107208. eCollection 2023 Jul 21. iScience. 2023. PMID: 37448563 Free PMC article.
-
COVID-19: Relative Risk of Non-Vaccinated to Vaccinated Individuals.Diseases. 2022 Nov 23;10(4):113. doi: 10.3390/diseases10040113. Diseases. 2022. PMID: 36547199 Free PMC article.
References
-
- European Centre for Disease Prevention Control (ECDC). Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA. Stockholm: ECDC; 11 Nov 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/overview-implementation-...
-
- European Centre for Disease Prevention Control (ECDC). Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA. Stockholm: ECDC; 23 Sep 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Overview-of-the...
-
- Nicolay N, Innocenti F, Beauté J, Učakar V, Grgič Vitek M, Poukka E, et al. Initial assessment of the COVID-19 vaccination’s impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021. Euro Surveill. 2021;26(48). 10.2807/1560-7917.ES.2021.26.48.2101030 - DOI - PMC - PubMed
-
- Meslé MM, Brown J, Mook P, Hagan J, Pastore R, Bundle N, et al. Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021. Euro Surveill. 2021;26(47). 10.2807/1560-7917.ES.2021.26.47.2101021 - DOI - PMC - PubMed
-
- European Centre for Disease Prevention Control (ECDC). Assessment of the current SARS-CoV-2 epidemiological situation in the EU/EEA, projections for the end-of-year festive season and strategies for response, 17th update. Stockholm: ECDC; 24 Nov 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-SARS-CoV-2-...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous